Overexpression of a hexa-histidine and T7 peptide-tagged human ribonucleotide reductase small subunit, R2 in Escherichia coli and the generation of human R2 antibodies

International Journal of Oncology

Volumn 10, Issue 3, 1997, Pages 515-520

  Kuo, Mei Ling ^a   Kinsella, Timothy J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

DNA repair; DNA replication; ribonucleotide reductase

Indexed keywords

HEXA HISTIDINE; HYBRID PROTEIN; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; RIBONUCLEOTIDE REDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ESCHERICHIA COLI; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0031000645     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.3.515     Document Type: Article

References (29)

1. Reichard P: From RNA to DNA, why so many ribonucleotide reductases? Science 260: 1773-1777, 1993.
2. Eriksson S and Martin DW Jr: Ribonucleotide reductase in cultured mouse lymphoma cells. Cell cycle-dependent variation in the activity of subunit protein M2. J Biol Chem 256: 9436-9440, 1981.
3. Engstrom Y, Eriksson S, Jildevik I, Skog S, Thelander L and Tribukait B: Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem 260: 9114-9116, 1985.
4. Eriksson S, Graslund A, Skog S, Thelander L and Tribukait B: Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J Biol Chem 259: 11695-11700, 1984.
5. Bjorklund S, Skog S, Tribukait B and Thelander L: S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry 29: 5452-5458, 1990.
6. Thompson DP, Carter GL and Cory JG: Changes in messenger RNA levels for the subunits of ribonucleotide reductase during the cell cycle of leukemia L1210 cells. Cancer Commun 1: 253-260, 1989.
7. Albert DA, Nodzcnski E and Yim G: Cell cycle regulation of ribonuclcotide reductase M2 subunit specific RNA in wild type and mutant S49 cells. Adv Exp Mcd Biol 253B: 93-97, 1989.
8. Mann G J, Musgrove EA, Fox RM and Thelander L: Ribonucleotide reductase Ml subunit in cellular proliferation, quiescence, and differentiation. Cancer Res 48: 5151-5156, 1988.
9. Tay DL, Bhathal PS and Fox RM: Quantitation of G0 and G1 phase cells in primary carcinomas. Antibody to M1 subunit of ribonucleotide reductase shows G1 phase restriction point block. J Clin Invest 87: 519-527, 1991.
10. Elledge SJ, Zhou Z, Allen JB and Navas TA: DNA damage and cell cycle regulation of ribonucleotide reductase. (Review). Bioessays 15: 333-339, 1993.
11. Huang P and Plunkett W: Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event. Cancer Chemother Pharmacol 36: 181-188, 1995.
12. Bitonti AJ, Bush TL, Lewis MT and Sunkara PS: Response of human colon and prostate tumor xenografts to (E)-2′-deoxy-2′-(fluoromethylene) cylidine, an inhibitor of ribonucleotide reductase. Anticancer Res 15: 1179-1182, 1995.
13. Kuo ML, Kunugi KA, Lindstrom MJ and Kinsella TJ: The interaction of hydroxyurea and iododeoxyuridine on the radioscnsitivity of human bladder cancer cells. Cancer Res 55: 2800-2805, 1995.
14. Fram RJ and Kufe DW: Inhibition of DNA excision repair and the repair of X-ray-induced DNA damage by cytosine and hydroxyurea. Pharmacol Therapeut 31: 165-176, 1985.
15. Fram RJ and Kufe DW: Effect of 1-beta-D-arabinofuranosyl cytosine and hydroxyurea on the repair of X-ray induced DNA single-strand breaks in human leukemic blasts. Biochem Pharmacol 34: 2557-2560, 1985.
16. Nordlund P and Ekluncl H: Structure and function of the Escherichia coli ribonucleotide reductase protein R2. J Mol Biol 232: 123-164, 1993.
17. Filatov D, Ingemarson R, Graslund A and Thelander L: The role of herpes simplex virus ribonucleotide reductase small subunit carboxyl terminus in subunit interaction and formation of irontyrosyl center structure. J Biol Chem 267: 15816-15822, 1992.
18. Nielsen BB, Kauppi B, Thelander M, Thelander L, Larsen IK and Eklund H: Crystallization and crystallographic investigations of the small subunit of mouse ribonucleotide reductasc. FEBS Lett 373: 310-312, 1995.
19. Scedorf K, Oltersdorf T, Krammer G, Rowekamp W: Identification of early proteins of the human papilloma viruses type 16 (HPV16) and type 18 (HPV18) in cervical carcinoma cells. EMBO J 6: 139-144, 1987.
20. Yen Y, Grill SP, Dutschman GE, Change CN, Zhou BS and Cheng YC: Characterization of a hydroxyurea-resistant human KB cell line with supersensitivity to 6-thioguanine. Cancer Res 54: 3686-3691, 1994.
21. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Plainview, New York, pp5.30-5.90, 1989.
22. Studier FW: Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system. J Mol Biol 219: 37-44, 1991.
23. Standart NM, Bray SJ, George EL, Hunt T and Ruderman JV: The small subunit of ribonucleotide reductase is encoded by one of the most abundant translationally regulated maternal RNAs in clam and sea urchin eggs. J Cell Biol 100: 1968-1976, 1985.
24. Thelander M, Graslund A and Thelander L: Subunit M2 of mammalian ribonucleotide reductase. Characterization of a homogeneous protein isolated from M2-overproducing mouse cells. J Biol Chem 260: 2737-2741, 1985.
25. Wehland J, Schroder HC and Weber K: Amino acid sequence requirements in the epitope recognized by the alpha-tubulin-specific rat monoclonal antibody YL1/2. EMBO J 3: 1295-1300, 1984.
26. Saeki T, Takahash T, Okabe M, Furuya A, Hanai N, Yamagami K, Mandai K, Moriwaki S, Doihara H, Takasha S and Salomon D: Immunohistochemical detection of ribonucleotide reductase in human breast tumors. Int J Oncol 6: 523-529, 1995.
27. Kaye SB: Gemicitabine: Current status of Phase I and II trials. J Clin Oncol 12: 1527-31, 1994.
28. Johnston PG, Lenz HJ, Danenberg KD, Leichman L, Leichman CG, Allegra CJ, Danenberg PV: Thymidylate synthase protein and gene expression predicts for response to 5-fluorouracil and leucovorin chemotherapy in patients with colorectal and gastric cancer. Cancer Res 55: 1407-1412, 1995.
29. Johnston PG, Mick R, Relant W, Behan KA, Dolan E, Ratain M, Beckmann E, Weichselbaum RR, Allegra CJ, Yokes EE: Thymidylate synthase expression predicts for response to neoadjuvant induction chemotherapy in advanced head and neck cancer. J Natl Cancer Inst (In press).